Redox Cycling of MPP+: Evidence for a New Mechanism Involving Hydride Transfer with Xanthine Oxidase, Aldehyde Dehydrogenase, and Lipoamide Dehydrogenase
Overview
Biology
General Medicine
Affiliations
MPP+ is redox active in the presence of cytochrome P450 reductase and induces the formation of O2.- and HO(.). In this study, we report the redox cycling capability of MPP+ with additional enzymes and with UV photolysis detected through ESR techniques. The treatment of MPP+ with UV light resulted in the production of HO. trapped as a spin adduct. Two of the enzymes examined in this study, xanthine oxidase and aldehyde dehydrogenase, produced O2.- in the presence of substrate. However, when MPP+ was added to the incubations, the radical trapped by DMPO was HO(.). This indicates that MPP+ redox cycles in the presence of these two enzymes or UV light, which produces HO.. Our data also suggest that MPP+ is reduced by lipoamide dehydrogenase. MPP+ stimulated the oxidation of reduced nicotinamide adenine dinucleotide (NADH) by the enzyme at concentrations between 2 mM and 8 mM of MPP+. Higher concentrations of MPP+ inhibited lipoamide dehydrogenase. MPP+ appears to be redox active with a number of redox enzymes. The mechanism involved may be hydride transfer from the enzymes to MPP+, rather than a direct single-electron reduction.
Curtis W, Seeds W, Mattson M, Bradshaw P Cells. 2022; 11(15).
PMID: 35954260 PMC: 9367803. DOI: 10.3390/cells11152416.
Neuroprotective Effect of Astersaponin I against Parkinson's Disease through Autophagy Induction.
Zhang L, Park J, Zhao D, Kwon H, Yang H Biomol Ther (Seoul). 2021; 29(6):615-629.
PMID: 34210894 PMC: 8551730. DOI: 10.4062/biomolther.2021.004.
Early Life Stress, Depression And Parkinson's Disease: A New Approach.
Dalle E, Mabandla M Mol Brain. 2018; 11(1):18.
PMID: 29551090 PMC: 5858138. DOI: 10.1186/s13041-018-0356-9.
Machado V, Zoller T, Attaai A, Spittau B Int J Mol Sci. 2016; 17(2).
PMID: 26821015 PMC: 4783885. DOI: 10.3390/ijms17020151.
Mitochondrial mechanisms of redox cycling agents implicated in Parkinson's disease.
Lopert P, Patel M J Neural Transm (Vienna). 2015; 123(2):113-23.
PMID: 25749885 PMC: 5049695. DOI: 10.1007/s00702-015-1386-4.